Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine: Immunological Superiority of the 2-dose Schedule Versus 2-dose and 3-dose schedules of HPV-6/11/16/18 Vaccine; Results of a Randomised, Multicentre, Immunogenicity Trial Up to Month 24

Authors
Publication date
1 January 2015
Publisher

Abstract

Oral Session 2: Viral Vaccine: abstract no. OS 2-

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HKU Scholars Hub

    redirect
    oaioai:hub.hku.hk:10722/221584
    Last time updated on 01/06/2016